News & Updates
Inside Innovation
The latest news and advances from the world's most exciting life science cluster.
Avalyn Pharma raises $175M for pulmonary fibrosis treatments
Avalyn Pharma, a Seattle-based biopharma company, raised $175 million in a recent Series C funding round. Avalyn will use the funds to support development of
Cows burp out too much methane. This biotech startup is making a bovine Beano.
Seattle-based biotech company Lumen Bioscience is working to reduce atmospheric harm by reducing cows’ methane emissions. The company is developing a manufactured enzyme to prevent
Seagen’s cancer drug succeeds in ‘must-win’ trial
Bothell-based biotech company Seagen found success in a clinical trial testing a variety of cancer drugs. Roughly 1,000 participants joined the trial and some received
Lumen Bioscience wins historic $1.5M Wilkes Center Climate Prize
Lumen Bioscience, a Seattle-based biotech company, won the University of Utah’s $1.5 million Wilkes Center Climate Prize. 77 other candidates were submitted for the Wilkes
Bonum Therapeutics CEO named Top Industry Leader of 2023 by PharmaVoice 100
John Mulligan, CEO and founder of Seattle-based Bonum Therapeutics was named a Top Industry Leader in PharmaVoice 100’s 2023 Entrepreneurs ranking. PharmaVoice 100 celebrates the
Seattle biotech startup Deverra Therapeutics raising cash to develop cellular immunotherapies
Deverra Therapeutics, a biotech startup based in Seattle, has raised $2.4 million to support its immunotherapy platform, according to a recent SEC filing. With the
Otsuka and Shape Therapeutics: Revolutionizing Ocular Disease Treatments
Shape Therapeutics, a Seattle-based biotech company, announced a new partnership with pharmaceutical entity Otsuka. Their efforts will focus on creating new eye disease treatments with
Allen Institute hits 20 years on the frontier of bioscience, and Seattle will be all aglow
In honor of the Allen Institute’s 20th anniversary, Seattle and King County now recognize Sept. 16, 2023, as “Open Science Day.” The Allen Institute, founded
Behind Drug Development: How AGC Biologics Brings Hope to Life
For Jean-Baptiste “JB” Agnus, the company’s purpose of bringing hope to patients fuels his work AGC Biologics. “Each individual, each team member at AGC Biologics,
Kathy Surace-Smith named a PSBJ Director of the Year
An employee at Nanostring Technologies, a Seattle-based biotech startup, was named a Business Journal director of the year for 2023. Kathy Surace-Smith is senior vice
Viome Life Sciences banks $86.5M round, partners with CVS to sell at-home diagnostic tests
Viome Life Sciences, a biotech startup in the Seattle area, acquired $86.5 million in Series C funding and confirmed that its gut microbiome test will
These are the 6 best big cities in the U.S. to launch a startup
Seattle ranks fifth in the best American cities to launch a startup company, according to a recent survey from Statista. The west coast city received